PINK1 and fatty liver disease: Mechanistic studies have revealed that cyanidin-3-O-glucoside (C3G) improves hepatic steatosis and glucose metabolism by upregulating the expression and mitochondrial localisation of PINK1 and Parkin, thereby promoting PINK1-mediated mitophagy [124].